PMC:7029759 / 26408-26516 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"637","span":{"begin":29,"end":35},"obj":"Chemical"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"A phase I trial demonstrated rhACE2 was well tolerated with no effects seen on the cardiovascular system 60."}

{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T553","span":{"begin":83,"end":104},"obj":"UBERON:0004535"}],"text":"A phase I trial demonstrated rhACE2 was well tolerated with no effects seen on the cardiovascular system 60."}

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T159","span":{"begin":83,"end":104},"obj":"Body_part"}],"attributes":[{"id":"A159","pred":"fma_id","subj":"T159","obj":"http://purl.org/sig/ont/fma/fma7161"}],"text":"A phase I trial demonstrated rhACE2 was well tolerated with no effects seen on the cardiovascular system 60."}

{"project":"LitCovid-PD-UBERON","denotations":[{"id":"T18","span":{"begin":83,"end":104},"obj":"Body_part"}],"attributes":[{"id":"A18","pred":"uberon_id","subj":"T18","obj":"http://purl.obolibrary.org/obo/UBERON_0004535"}],"text":"A phase I trial demonstrated rhACE2 was well tolerated with no effects seen on the cardiovascular system 60."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T240","span":{"begin":0,"end":1},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T241","span":{"begin":83,"end":104},"obj":"http://purl.obolibrary.org/obo/UBERON_0004535"},{"id":"T242","span":{"begin":83,"end":104},"obj":"http://www.ebi.ac.uk/efo/EFO_0000791"}],"text":"A phase I trial demonstrated rhACE2 was well tolerated with no effects seen on the cardiovascular system 60."}

{"project":"LitCovid-sentences","denotations":[{"id":"T169","span":{"begin":0,"end":108},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"A phase I trial demonstrated rhACE2 was well tolerated with no effects seen on the cardiovascular system 60."}